Crossmark

Clostridium myonecrosis — a rare and underdiagnosed condition in the elderly: a case with severe skipping lesions and an overview of treatment guidelines

Crossref DOI link: https://doi.org/10.1186/s12245-022-00458-w

Published Online: 2022-10-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van Asbroeck, Ellen

Vasileiadou, Ourania

De Laere, Sylvie

Van Hedent, Eddy

Devue, Katleen
License Information

Text and Data Mining valid from 2022-10-05

Version of Record valid from 2022-10-05
More Information

Article History

Received: 25 April 2022

Accepted: 17 September 2022

First Online: 5 October 2022

Declarations

:

: The ethic committee ASZ Aalst (Commissie voor medische ethiek 06052) waived the need for approval for clostridium myonecrosis — 09/22/CME/ASZ. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Written informed consent was obtained from the next of kin (niece) for publication of this case report and accompanying images.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below